European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- -

European Pharmacopoeia (Ph. Eur.) Monograph 0478 establishes essential quality standards for oral tablets, covering classification, uniformity of dosage, and disintegration, with specific requirements for scored tablet functionality. The monograph mandates strict tests for uniformity of content (Chapter 2.9.6) and mass (Chapter 2.9.5), along with specific criteria for break-mark functionality, requiring 85%–115% uniformity for fractional doses. For further detailed technical guidance, professionals can refer to the official EDQM Knowledge Base gmp-compliance.org

Mastering the Standard: A Guide to Ph. Eur. Monograph 0478 for Tablets European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

While disintegration shows the tablet breaking apart, dissolution measures the rate at which the active substance enters solution. Under recent policies, a suitable product-specific dissolution test is mandatory for most immediate-release solid dosage forms to confirm batch-to-batch consistency. 3. Uniformity of Dosage Units (General Chapter 2.9.40) European Pharmacopoeia (Ph

The Ph. Eur. monograph for Tablets - 0478 plays a crucial role in ensuring the quality of tablet formulations. By following the guidelines set out in the monograph, manufacturers can ensure that their tablets meet the required standards for quality, purity, and strength. Regulatory authorities and control laboratories also use the monograph to evaluate the quality of tablets. The active substance (degradation products

1. The active substance (degradation products, residual solvents).
2. The excipients and manufacturing process (e.g., peroxides from PVP, formaldehyde from cross-linked polymers).